SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Sodium Chloride 0.9% In Plastic Container patents expire, and what generic alternatives are available?
Sodium Chloride 0.9% In Plastic Container is a drug marketed by B Braun, Fresenius Kabi Usa, Fresenius Medcl, Gvs Tm, Hospira, Laboratorios Grifols, Liebel-flarsheim, Otsuka Icu Medcl, Abbott, Baxter Hlthcare, Icu Medical Inc, Jubilant Cadista, Miles, Nephron, and Taro. and is included in twenty-seven NDAs.
The generic ingredient in SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
- What are the global sales for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
Summary for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 27 |
| Finished Product Suppliers / Packagers: | 22 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| DailyMed Link: | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER at DailyMed |
Pharmacology for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
| Drug Class | Osmotic Laxative |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |

